MedTrace Logo

Portal-724 MEMS for Medication Adherence Patients Taking HCV Medications

NCT02858050 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2023-04-13

Study results available
· View outcomes & findings →

Summary

The study will look at real-time adherence monitoring with Portal-724 MEMS cap. It integrates medication bottle, Smart Cap, Pill Dispenser, Embedded Computer, Embedded Cellular Modem and Tamper Proof apparatus. This device is capable of transmitting pill dispensing events from the patient's home to the Cloud over Cellular and IP networks. The transmission is done in real time if cellular coverage is above 1-bar, but if the cell signal is not available or if the signal is below the threshold, then the device Store-and-Forward feature is automatically activated. The patient will be randomized to real-time monitoring or to have monitoring data download monthly at each study visit while taking hepatitis C medications

Conditions

  • Adherence

Interventions

DEVICE

Portal-724 MEMs Cap

Sponsors & Collaborators

Principal Investigators

  • Jihad Slim, MD · Saint Micahel's Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-09
Primary Completion
2017-11-30
Completion
2018-01-25

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02858050 on ClinicalTrials.gov